Abstract
Objective: To systematically evaluate the effects of Shenfu Injection on immune function of sepsis patients by meta-analysis. Methods: The randomized controlled trials of Shenfu Injection in the treatment of sepsis published from 2000 to February 2021 were searched in CNKI, WanFang database and VIP database. The control group was treated with routine treatment; The experimental group was treated with Shenfu Injection on the basis of routine treatment. The included literature was evaluated by Cochrane bias risk evaluation table, and Shenfu Injection was used to treat patients with sepsis with RevMan 5.3 software. The results of meta-analysis were as reported. Conclusion: However, due to the limitation of the quality and quantity of the included research, multi center, large sample volume and high-quality RCT are still needed to verify the research results.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
